These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 16356999)
1. Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: how strong is the evidence? Bannwarth BG BMJ; 2005 Dec; 331(7530):1474. PubMed ID: 16356999 [No Abstract] [Full Text] [Related]
2. Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option. Lewis MR; Kay D BMJ; 2005 Dec; 331(7530):1474. PubMed ID: 16356997 [No Abstract] [Full Text] [Related]
3. Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: what does evidence from randomised trials show about celecoxib? Underhill JL BMJ; 2005 Dec; 331(7530):1474-5. PubMed ID: 16356996 [No Abstract] [Full Text] [Related]
4. Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: why were patients at major risk excluded? Puccetti L BMJ; 2005 Dec; 331(7530):1474. PubMed ID: 16356998 [No Abstract] [Full Text] [Related]
5. Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: study conclusions do not reflect findings for celecoxib. Feczko J BMJ; 2005 Dec; 331(7530):1473-4. PubMed ID: 16356991 [No Abstract] [Full Text] [Related]
6. Coxibs and NSAIDs: a chronology of confusion. Lipman AG J Pain Palliat Care Pharmacother; 2006; 20(4):5-7. PubMed ID: 17182501 [No Abstract] [Full Text] [Related]
7. NSAIDs sometimes cause fatal stomach bleeding. Health News; 2005 Nov; 11(11):4-5. PubMed ID: 16294426 [No Abstract] [Full Text] [Related]
8. Upper gastrointestinal complications: the causes, consequences, and clinical outcomes. Am J Manag Care; 2001 Sep; 7(12 Suppl):S397-401. PubMed ID: 11570031 [TBL] [Abstract][Full Text] [Related]
9. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365 [TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study. Mamdani M; Juurlink DN; Kopp A; Naglie G; Austin PC; Laupacis A BMJ; 2004 Jun; 328(7453):1415-6. PubMed ID: 15138157 [No Abstract] [Full Text] [Related]
11. Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastrointestinal bleeding. Lee I; Cryer B Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):597-612. PubMed ID: 21944413 [TBL] [Abstract][Full Text] [Related]
12. The practice implications of cardiovascular risks in NSAIDs. Hainsworth T Nurs Times; 2005 Jun 28-Jul 4; 101(26):26-7. PubMed ID: 16010838 [TBL] [Abstract][Full Text] [Related]
13. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered]. MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036 [No Abstract] [Full Text] [Related]
14. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study. Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523 [TBL] [Abstract][Full Text] [Related]
15. Celecoxib-induced upper gastrointestinal hemorrhage and ulceration. Crawford AS; White JG South Med J; 2002 Dec; 95(12):1444-6. PubMed ID: 12597315 [TBL] [Abstract][Full Text] [Related]
16. COX-2 inhibitors and Celebrex: safe or suspect? Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776 [No Abstract] [Full Text] [Related]
17. Nonsteroidal gastropathy in dentistry--issues and controversies in patient's management. Afolabi AO; Adekanle OA Niger J Med; 2009; 18(1):39-42. PubMed ID: 19485146 [TBL] [Abstract][Full Text] [Related]
19. NSAIDs and alcohol: never the twain shall mix? Pfau PR; Lichenstein GR Am J Gastroenterol; 1999 Nov; 94(11):3098-101. PubMed ID: 10566697 [No Abstract] [Full Text] [Related]
20. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study. Rahme E; Nedjar H; Bizzi A; Morin S Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]